DOI: 10.1055/s-00000167

International Journal of Angiology

References

Yoshida T, Yamagishi S, Matsui T , et al.
Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation.

J Int Med Res 2008;
36 (2) 237-243

Download Bibliographical Data

Search in:
Access: